MétaCan
Menu
Back to cohort
Record W176030775

How Countries of the Southern African Development Community (SADC) can use the World Trade Organisation and the European Community flexibilities for better access to affordable HIV/AIDS Medicines

2008· book-chapter· en· W176030775 on OpenAlexaboutno aff
Stephen Kingah, Stefaan Smis, Fredrik Söderbaum

Bibliographic record

VenueWestminsterResearch (University of Westminster) · 2008
Typebook-chapter
Languageen
FieldEconomics, Econometrics and Finance
TopicPharmaceutical Economics and Policy
Canadian institutionsnot available
Fundersnot available
KeywordsTRIPS architectureDeclarationInterimIntellectual propertyTRIPS AgreementInternational tradeBusinessDeveloping countryEconomic growthPolitical scienceEconomicsLawEngineering
DOInot available

Abstract

fetched live from OpenAlex

This paper discusses the ways in which countries of the Southern African\n\nDevelopment Community (SADC) can maximise the patent-related advantages that\n\nare available to developing countries and regions by flexibilities offered by the World\n\nTrade Organisation (WTO) and the European Community (EC). Article 31 of the\n\nAgreement on Trade Related Aspects of Intellectual Property (TRIPs) provided only\n\nlimited derogation to the exclusive rights that a patent holder may have under Article\n\n28 of TRIPs. The entry into force of the agreement in developing countries entailed\n\nthat important (cheaper) generic medicine manufacturers such as Brazil, China, India\n\nand South Africa would not be able to use TRIPs to supply needed medicines. This\n\nproblem became known as the ‘Doha Paragraph 6 Problem’ as it was included in the\n\n2001 Doha Declaration under the section of TRIPs and public health. The\n\nDeclaration called for a solution to the problem by the end of 2002. Although this\n\ndeadline was not met, an interim solution to the problem was worked out by the\n\nTRIPs Council of the WTO. This interim solution provided generous options for countries in need. The decision was integrated into the TRIPs Agreement as a\n\npermanent amendment in December 2005. In the EC, Regulation 816/2006 was\n\nadopted to apply the system which had been crafted at the WTO. So far only one\n\ncountry (Rwanda) has used the system to purchase affordable HIV/AIDS medicines\n\nfrom Canada. SADC is a region that has high levels of prevalence rates of HIV/AIDS.\n\nThe WTO and EC flexibilities have not been used by SADC countries. One of the\n\nadvantages of the flexibilities is that benefits are specifically guaranteed to regional\n\ntrade arrangements like SADC’s. Why has there been use an under-utilisation of the\n\nflexibilities? This paper argues that elements such as lack of awareness on the\n\nSADC side, the complicated nature of the procedures in the use of the flexibilities,\n\nand the actions of international charities explain the limited use of the system in SADC. It advocates for a more proactive involvement of SADC and its member states\n\nin the negotiations on the various ways in which access to medical products\n\n(especially second line HIV/AIDS medicines) can be eased for SADC’s citizens.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies
Consensus categoriesScience and technology studies
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.886
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0020.003
Scholarly communication0.0000.000
Open science0.0020.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.150
GPT teacher head0.269
Teacher spread0.119 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2008
Admission routes1
Has abstractyes

Explore more

Same venueWestminsterResearch (University of Westminster)Same topicPharmaceutical Economics and PolicyFrench-language works237,207